CNBC Market Survival Guide: What to Do Now
"They've got to understand why they invested. If it's for the long run, they ought to, frankly, stop listening to us jabber away, and go about their business. If they have a short-term time horizon, they didn't belong in there in the first place, and if they have some money earmarked for equities, do a dollar-cost-averaging system. Start getting in, my guess is, eight to 12 months from now, equities will be nicely higher than they will be at today's low at the opening."
Bob Doll, BlackRock Vice Chairman & Global CIO of Equities
Energizing Your Portfolio
“We do have a lot of energy stocks, and we’re certainly holding on to them. Oil is still very elevated relative to where it was a year ago or two or three years ago. So I think names like Exxon and Marathon Oil, a name I was going to talk about today, these are stocks that have come down considerably, and I think there is great opportunity there.”
Buckingham recommends: Exxon and Marathon Oil
John Buckingham, Al Frank Asset Management
The Case for Biotech Stocks
"Biotech stocks have actually exhibited more sense of maturity in the last few years. A lot of these things are flush with cash, they actually have the pipeline and the marketplace, not really beholden to the economic cycle the way a lot of other things are, whether it's retail, whether it's energy stocks, in a recessionary environment. What we've seen specifically with some of the bigger names is almost a flight to quality, and I think we may see this again in the next few days."
John O'Donohue, S. G. Cowen Head Trader